Progress in Parkinson's disease.
Schapira
A H
AH
D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001921:Brain / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology; D003072:Cognition Disorders / Q000175:diagnosis / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents / Q000008:administration & dosage / Q000009:adverse effects; D042241:Early Diagnosis; D006801:Humans; D020961:Lewy Body Disease / Q000175:diagnosis / Q000503:physiopathology; D009480:Neuropharmacology / Q000639:trends*; D010300:Parkinson Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D004298:Dopamine